Immersive Virtual Reality and Central Sensitization in People With Chronic Pain

Withdrawn before enrolling · Not applicable

Conditions studied: Chronic Pain

In brief

Patients with chronic low back pain from Dr. Robert Edwards' study at the Brigham \& Women's Pain Institute that examines sensory and pain perceptions in patients with chronic pain who use opioids will complete quantitative sensory testing (QST) and current pain levels will be obtained. Subsequently, 20-minutes of Immersive Virtual Reality (IVR) will be completed and then QST testing will be completed again post-IVR.

Key facts

Study ID

NCT04609787

Run by

Tufts University

People needed

0

Starts

2021-01-05

Expected to finish

2023-05-01

Last updated by the study team

2023-11-28

Who can join

Age: 25 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 25-65
• CLBP lasting for more than 6 months as the primary complaint
• Typical pain ratings ≥ 4/10 on a visual analogue scale
• Currently prescribed oral opioid therapy and under consideration for dose reduction by the prescribing clinician.
• able to speak and understand English

You may not qualify if…

• Evidence of delirium, dementia, psychosis, or other cognitive impairment preventing completion of study procedures
• current (i.e., active) substance use disorder (SUD).
• history of myocardial infarction or other serious cardiovascular condition.
• current peripheral neuropathy.
• current pregnancy, or intention to become pregnant during the study.
• current intrathecal pump
• history of seizures
• history severe motion sickness

Where it is running

• Brigham and Women's Hospital — Chestnut Hill, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.